Editas Medicine reported cash from operations of -$30.84M and free cash flow of -$30.84M for the quarter ended Sep 2025, up 41.3% year over year. This cash flow statement covers 43 quarters of results from Mar 2015 through Sep 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||||||||||||
| Net Income | -65.64M | -56.75M | -55.26M | -39.10M | -41.44M | -50.28M | -53.69M | -55.73M | -60.73M | -47.45M | -40.28M | -45.02M | -18.86M | -61.96M | -67.61M | -62.14M | -45.39M | -75.66M | -51.48M | -25.12M | |||||||||||||||||||||||
| Share-based CompensationStock Comp. | 10.02M | 12.20M | 3.25M | 10.01M | 7.66M | 11.43M | 6.62M | 5.88M | 5.36M | 6.16M | 6.19M | 4.73M | 5.34M | 7.58M | 5.01M | 4.80M | 4.02M | 2.98M | 2.66M | 2.23M | |||||||||||||||||||||||
| Gains from Investment SecuritiesGains Investment | |||||||||||||||||||||||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 3.72M | ||||||||||||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -40.10M | -49.48M | -38.96M | -40.78M | -34.58M | -49.23M | -37.84M | -48.00M | -42.27M | -35.77M | -38.71M | -35.46M | -22.24M | -49.87M | -57.06M | -52.59M | -50.76M | -47.80M | -50.21M | -30.84M | |||||||||||||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.69M | 0.78M | 1.25M | 1.72M | 1.88M | 1.33M | |||||||||||||||||||||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | |||||||||||||||||||||||||||||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 4.99M | -5.38M | -0.34M | -0.08M | 0.02M | 1.10M | -0.66M | -0.59M | 5.03M | -4.90M | 2.04M | 0.14M | 7.76M | -9.94M | -0.00M | -0.12M | 16.14M | -15.76M | 0.08M | 7.54M | |||||||||||||||||||||||
| Change in Account PayablesChange Payables | 1.30M | 2.02M | -3.83M | -1.16M | 1.84M | -0.23M | 1.48M | 0.42M | 2.69M | -0.56M | -0.70M | 2.36M | -2.59M | -1.46M | 7.42M | -1.25M | -7.00M | -0.03M | 1.26M | -3.56M | |||||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | -0.29M | -9.56M | 3.55M | -3.42M | 5.27M | -3.98M | 4.38M | -0.89M | 10.99M | 1.43M | -3.79M | 2.38M | 4.09M | -2.69M | -3.84M | 1.01M | 17.15M | 1.69M | 0.58M | -0.54M | |||||||||||||||||||||||
| Other Working Capital ChangesOther WC Changes | -5.77M | -5.55M | -0.15M | -5.67M | -11.33M | -5.52M | 2.18M | -8.46M | -4.22M | -2.00M | |||||||||||||||||||||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 1.38M | 1.99M | 0.80M | 2.34M | 2.85M | 2.25M | 0.63M | 0.61M | 0.62M | 1.84M | 1.33M | 0.24M | 1.31M | 1.87M | 3.49M | 2.92M | 0.54M | -1.02M | -0.00M | ||||||||||||||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | -0.01M | 0.15M | |||||||||||||||||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 30.50M | 130.75M | 74.20M | 73.13M | 84.33M | 119.00M | 119.75M | 116.10M | 78.50M | 65.91M | 41.70M | 49.00M | 102.90M | 83.35M | 55.45M | 86.90M | 31.49M | 56.50M | 42.50M | 40.01M | |||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -108.89M | 3.24M | 4.79M | -39.66M | -22.84M | 56.37M | -4.00M | 89.23M | -27.53M | 23.27M | 12.98M | -102.82M | 62.84M | -4.75M | 51.95M | 83.98M | 30.96M | 56.39M | 42.65M | 39.57M | |||||||||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 8.67M | 12.00M | 16.57M | 2.50M | 0.43M | 0.22M | 0.15M | 0.61M | 0.43M | 0.48M | 0.19M | 0.13M | 0.27M | 0.23M | |||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 9.10M | 261.47M | 17.08M | 2.50M | 1.06M | 0.22M | 0.37M | 0.08M | 0.62M | 117.53M | 0.51M | 0.19M | 0.32M | 55.51M | -1.44M | 7.41M | 17.17M | ||||||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 1.72M | 0.91M | 1.30M | 1.14M | 2.87M | 1.21M | |||||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | -0.11M | 249.47M | -0.01M | 0.00M | 117.10M | 1.44M | 7.18M | 17.15M | |||||||||||||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||||||||
| Change in Cash | -139.89M | 215.24M | -17.08M | -77.95M | -56.37M | 7.36M | -41.48M | 41.30M | -69.18M | -12.50M | 91.80M | -138.28M | 41.11M | -54.42M | -4.79M | 31.39M | 35.71M | 7.15M | -0.15M | 25.90M | |||||||||||||||||||||||
| Free Cash FlowFCF | -41.48M | -51.46M | -39.76M | -43.13M | -37.43M | -51.48M | -38.48M | -48.62M | -42.90M | -37.61M | -40.04M | -35.70M | -23.55M | -51.74M | -60.56M | -55.51M | -51.30M | -46.77M | -50.21M | -30.84M | |||||||||||||||||||||||
| Net Cash FlowNCF | -139.89M | 215.24M | -17.08M | -77.95M | -56.37M | 7.36M | -41.48M | 41.30M | -69.18M | -12.50M | 91.80M | -138.28M | 41.11M | -54.42M | -4.79M | 31.39M | 35.71M | 7.15M | -0.15M | 25.90M |